×
About 772 results

ALLMedicine™ Neonatal Hypoglycemia Center

Research & Reviews  381 results

The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.
https://doi.org/10.1055/s-0040-1716730
American Journal of Perinatology; Eid J, Kechichian T et. al.

Sep 7th, 2020 - Insulin resistance (IR) increases during pregnancy which can lead to hyperinsulinemia, gestational diabetes mellitus (GDM), and neonatal hypoglycemia (NH), especially in obese women. Glucose tolerance testing (GTT) is used clinically to evaluate I...

Management and appropriate use of diazoxide in infants and children with hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 18th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only FDA-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have highlighted that di...

Galactokinase deficiency: lessons from the GalNet registry.
https://doi.org/10.1038/s41436-020-00942-9
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Rubio-Gozalbo ME, Derks B et. al.

Aug 18th, 2020 - Galactokinase (GALK1) deficiency is a rare hereditary galactose metabolism disorder. Beyond cataract, the phenotypic spectrum is questionable. Data from affected patients included in the Galactosemias Network registry were collected to better char...

Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing don...
https://doi.org/10.1038/s41372-020-00776-y
Journal of Perinatology : Official Journal of the California Perinatal Association; Sen S, Andrews C et. al.

Aug 12th, 2020 - Examine neonatal hypoglycemia (NH) outcomes based on type of feeding provided with first dextrose gel. Retrospective matched cohort study of 99 infants ≥35 weeks gestational age who received dextrose gel in combination with breastfeeding, formula ...

Impact of Maternal HbA1C Levels ≤6% and Race in Non-Diabetic Pregnancies on Birthweight...
https://doi.org/10.1016/j.jpeds.2020.08.026
The Journal of Pediatrics; Kumar N, Kumar P et. al.

Aug 11th, 2020 - To evaluate whether pregnancy HbA1c levels of ≤6% and maternal race impacts neonatal hypoglycemia and birthweight, and whether diabetes and beta blocker use during pregnancy additively impacts neonatal outcomes. Retrospective chart review of 4769 ...

see more →

Guidelines  1 results

Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British...
https://doi.org/10.1177/0890334419846128
Journal of Human Lactation : Official Journal of International Lactation Consultant Association; Hawdon JM

May 5th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

see more →

Clinicaltrials.gov  383 results

The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.
https://doi.org/10.1055/s-0040-1716730
American Journal of Perinatology; Eid J, Kechichian T et. al.

Sep 7th, 2020 - Insulin resistance (IR) increases during pregnancy which can lead to hyperinsulinemia, gestational diabetes mellitus (GDM), and neonatal hypoglycemia (NH), especially in obese women. Glucose tolerance testing (GTT) is used clinically to evaluate I...

Management and appropriate use of diazoxide in infants and children with hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 18th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only FDA-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have highlighted that di...

Galactokinase deficiency: lessons from the GalNet registry.
https://doi.org/10.1038/s41436-020-00942-9
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Rubio-Gozalbo ME, Derks B et. al.

Aug 18th, 2020 - Galactokinase (GALK1) deficiency is a rare hereditary galactose metabolism disorder. Beyond cataract, the phenotypic spectrum is questionable. Data from affected patients included in the Galactosemias Network registry were collected to better char...

Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing don...
https://doi.org/10.1038/s41372-020-00776-y
Journal of Perinatology : Official Journal of the California Perinatal Association; Sen S, Andrews C et. al.

Aug 12th, 2020 - Examine neonatal hypoglycemia (NH) outcomes based on type of feeding provided with first dextrose gel. Retrospective matched cohort study of 99 infants ≥35 weeks gestational age who received dextrose gel in combination with breastfeeding, formula ...

Impact of Maternal HbA1C Levels ≤6% and Race in Non-Diabetic Pregnancies on Birthweight...
https://doi.org/10.1016/j.jpeds.2020.08.026
The Journal of Pediatrics; Kumar N, Kumar P et. al.

Aug 11th, 2020 - To evaluate whether pregnancy HbA1c levels of ≤6% and maternal race impacts neonatal hypoglycemia and birthweight, and whether diabetes and beta blocker use during pregnancy additively impacts neonatal outcomes. Retrospective chart review of 4769 ...

see more →

News  7 results

Can insulin plus metformin improve pregnancy outcomes in women with type 2 diabetes?
https://www.mdedge.com/fedprac/article/214703/obstetrics/can-insulin-plus-metformin-improve-pregnancy-outcomes-women-type-2/page/0/1?channel=53

Dec 23rd, 2019 - Currently, the multisite MOMPOD trial (Medical Optimization of Management of T2DM Complicating Pregnancy) is randomizing 950 women to insulin plus 1,000 mg metformin twice daily or insulin plus placebo. The primary outcome of the trial is a compos.

Glyburide failed to show noninferiority in gestational diabetes
https://www.mdedge.com/familymedicine/article/164700/diabetes/glyburide-failed-show-noninferiority-gestational-diabetes
Clinical Endocrinology News; Amy Karon

May 2nd, 2018 - A randomized, multicenter trial failed to find glyburide noninferior to insulin for treatment of gestational diabetes, investigators reported. The composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia was 27.

Both prepregnancy and gestational diabetes bode ill for babies
https://www.mdedge.com/obgyn/article/113717/diabetes/both-prepregnancy-and-gestational-diabetes-bode-ill-babies
Michele G. Sullivan

Sep 13th, 2016 - MUNICH – Pregestational maternal diabetes is even riskier for newborns than gestational diabetes, increasing the chance of neonatal hypoglycemia by 36 times over a normal pregnancy. Baby’s blood sugar isn’t the only thing in danger, though, Basili.

Maternal Hypertension Ups Infant's Stroke Risk
https://www.mdedge.com/neurology/article/55256/pediatrics/maternal-hypertension-ups-infants-stroke-risk
Patrice Wendling

Jul 12th, 2012 - MINNEAPOLIS – Maternal hypertension and intrapartum fever increase the risk for ischemic stroke in infants, a large retrospective analysis suggests. Gestational diabetes, a known risk factor for maternal hypertension and neonatal hypoglycemia, doe.

AAP Issues Guide for Neonatal Hypoglycemia
https://www.medpagetoday.com/pediatrics/generalpediatrics/25084

Feb 28th, 2011 - Action Points Explain that, according to a clinical report from the American Academy of Pediatrics, screening for and treating low neonatal blood glucose levels should only be done in newborns known to be at risk for neonatal hypoglycemia or who d...

see more →